Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Schizophrenia Recent news which mentions Schizophrenia Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet August 30, 2024 Tickers BMY EIX LUCY O Tags Schizophrenia EIX Stories That Matter From Benzinga Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia June 12, 2023 Tickers PMBHF Tags Management PMBHF News From Benzinga Psychedelics And Schizophrenia: What's The Link? February 19, 2023 Tags Psychedelics General Benzinga From Benzinga Tips on Managing Your Schizophrenia August 22, 2022 Tickers ALKS Tags NAMI Schizophrenia Education From 3BL Media: Corporate Social Responsibility, Energy and Health News Marketing & Marijuana: Why Responsibility Is So Important As Psychosis & Schizophrenia Among Youth Rise June 08, 2022 Tickers CBD CURLF Tags Psychosis marketing KQED From Benzinga Addex Expands Pipeline With Selective M4 PAM Program For Schizophrenia & Other Psychotic Disorders April 06, 2022 Tickers ADXN Tags Biotech Preclinical Phase Health Care From Benzinga Amid Russia's Invasion On Ukraine, Karuna Therapeutics Withdraws Guidance On Late-Stage Schizophrenia Trial February 24, 2022 Tickers KRTX Tags Schizophrenia KRTX General From Benzinga Cannabis Increases Odds Of This Disorder In Teens Despite Infrequent Use February 08, 2022 Tags contributors Benzinga Schizophrenia From Benzinga Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia February 08, 2022 Tickers ALKS Tags ALKS Schizophrenia News From Benzinga Alkermes Highlights Signs and Symptoms of Schizophrenia January 31, 2022 Tags Alkermes Health & Healthcare National Institute of Mental Health From 3BL Media: Corporate Social Responsibility, Energy and Health News FDA Gives Green Signal To Reviva Pharma's Late-Stage Schizophrenia Trial January 10, 2022 Tickers RVPH Tags Trading Ideas Benzinga FDA From Benzinga FDA Pushes Review Of BioXcel's Candidate For Agitation Associated With Neuropsychiatric Disorders December 01, 2021 Tickers BTAI Tags Market News Benzinga FDA From Benzinga Neurocrine Pens $2.6B Pact With Sosei Heptares For Neuro Targets November 22, 2021 Tickers NBIX Tags Health Care Contracts Biotechnology From Benzinga ATAI Life's Schizophrenia Candidate Shows Promising Action In Mid-Stage Study November 01, 2021 Tickers ATAI Tags Benzinga Trading Ideas Phase 2 Trial From Benzinga Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial November 01, 2021 Tickers TEVA Tags Market News Schizophrenia Benzinga From Benzinga Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations September 30, 2021 Tickers NERV Tags Biotech Health Care Phase 2 Trial From Benzinga Alkermes Announces Launch of 4th Annual Alkermes Pathways Research Awards® Program September 13, 2021 Tickers ALKS Tags bipolar disorder Alkermes Philanthropy & Cause Initiatives From 3BL Media: Corporate Social Responsibility, Energy and Health News FDA Approves First And Only Twice-Yearly Schizophrenia Drug September 01, 2021 Tickers JNJ Tags General Health Care Briefs From Benzinga Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review September 01, 2021 Tickers TEVA Tags FDA Benzinga Market News From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.